• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Health Care USD

+ Add to Watchlist

UBSEHLI:LX

211.78 USD 0.73 0.35%

As of 00:59:30 ET on 07/09/2014.

Snapshot for UBS Lux Equity Fund - Health Care USD (UBSEHLI)

Year To Date: +14.48% 3-Month: +8.44% 3-Year: +16.63% 52-Week Range: 166.57 - 215.36
1-Month: +2.52% 1-Year: +28.04% 5-Year: +16.60% Beta vs MXWO0HC: 0.98

Mutual Fund Chart for UBSEHLI

No chart data available.
  • UBSEHLI:LX 211.78
  • 1M
  • 1Y
Interactive UBSEHLI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBSEHLI

UBS Lux Equity Fund - Health Care USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of large and medium-sized companies from the health care sector, which includes pharmaceuticals, biotechnology, hospital supplies, medical technology, and health care services.

Inception Date: 05-27-1998 Telephone: 352-44-10-10-1 Tel
Managers: SCOTT D WILKIN / IAN MCINTOSH
Web Site: www.ubs.com

Fundamentals for UBSEHLI

NAV (on 2014-07-09) 211.78
Assets (M) (on 2014-07-09) 146.35
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for UBSEHLI

No dividends reported

Fees & Expenses for UBSEHLI

Front Load -
Back Load 2.00
Current Mgmt Fee 1.63
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.11

Top Fund Holdings for UBSEHLI

Filing Date: 04/30/2014
Name Position Value % of Total
Novartis AG 116,903 10,130,841 7.256%
Johnson & Johnson 97,500 9,875,775 7.074%
Roche Holding AG 30,320 8,884,729 6.364%
Eli Lilly & Co 120,000 7,092,000 5.080%
Gilead Sciences Inc 85,700 6,726,593 4.818%
Merck & Co Inc 114,612 6,711,679 4.807%
UnitedHealth Group Inc 85,400 6,408,416 4.590%
Allergan Inc/United States 30,500 5,058,120 3.623%
Pfizer Inc 160,312 5,014,559 3.592%
Novo Nordisk A/S 105,468 4,755,126 3.406%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil